This inventor holds 4 USPTO granted patents, plus 1 CIPO patent. Top assignee: Kirin Beer Kabushiki Kaisha. Active years: 1992-1996.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Maebashi, JP (1992 - 1993)
- Takasaki, JP (1996)
Company Filing History:
Years Active: 1992-1996
Title: Innovations of Tomoko Kashiwabara in the Pharmaceutical Sector
Introduction: Tomoko Kashiwabara, an accomplished inventor based in Maebashi, Japan, has made significant contributions to the field of pharmaceuticals. With four patents to her name, she focuses on innovative compounds that hold potential therapeutic benefits.
Latest Patents: Among her latest patents, Kashiwabara has developed pyridinecarboxyimidamide compounds and carboximidamide derivatives. These novel compounds are represented by specific chemical formulas, aimed at enhancing pharmaceutical applications. The compounds disclosed also include N-cyano-pyridinecarboximidate intermediates, which are crucial for creating N-cyano-N'-substituted-pyridinecarboximidamide derivatives. Moreover, her patents detail the process for synthesizing these compounds, the pharmaceutical agents that exhibit vasodilating effects, and therapeutic methods for patient dosing.
Career Highlights: Tomoko Kashiwabara is currently employed at Kirin Beer Kabushiki Kaisha, where she engages in innovative research and development initiatives. Her work there showcases her ability to merge scientific research with practical applications in pharmaceuticals.
Collaborations: Throughout her career, Kashiwabara has collaborated with notable colleagues, including Nobuyuki Ogawa and Toshio Izawa. These collaborations reflect her commitment to advancing research and enhancing the efficacy of therapeutic agents.
Conclusion: Tomoko Kashiwabara stands out as a pioneering inventor in pharmaceutical innovation. With her cutting-edge patents and collaborative spirit, she continues to contribute valuable advancements to the field, paving the way for future therapies and medications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
